These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 4355215)

  • 1. Clinical and laboratory investigations on man: systemic administration of potent interferon to man.
    Strander H; Cantell K; Carlström G; Jakobsson PA
    J Natl Cancer Inst; 1973 Sep; 51(3):733-42. PubMed ID: 4355215
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on antiviral and antitumor effects of human leukocyte interferon in vitro and in vivo.
    Strander H; Cantell K
    In Vitro Monogr; 1974; (3):49-56. PubMed ID: 4471024
    [No Abstract]   [Full Text] [Related]  

  • 3. Antibody levels to multiple viral antigens in systemic lupus erythematosus and some other connective tissue diseases.
    Vesikari T; Laitinen O
    Ann Clin Res; 1974 Aug; 6(4):207-14. PubMed ID: 4372935
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of a human interferon preparation on vaccine-induced rubella infection.
    Best JM; Banatvala JE
    J Biol Stand; 1975; 3(1):107-12. PubMed ID: 1126957
    [No Abstract]   [Full Text] [Related]  

  • 5. Prospects for the medical use of interferon in 1984.
    Postic B; Arroyo JC
    Henry Ford Hosp Med J; 1984; 32(2):116-22. PubMed ID: 6210270
    [No Abstract]   [Full Text] [Related]  

  • 6. [Fibroblast-interferon in the treatment of herpes zoster: a pilot study (author's transl)].
    Heidemann E; Wilms K; Treuner J; Niethammer D
    Dtsch Med Wochenschr; 1982 May; 107(18):695-7. PubMed ID: 6176414
    [No Abstract]   [Full Text] [Related]  

  • 7. Administration of human leukocyte interferon in herpes zoster. I. Safety, circulating, antiviral activity, and host responses to infection.
    Jordan GW; Fried RP; Merigan TC
    J Infect Dis; 1974 Jul; 130(1):56-62. PubMed ID: 4601181
    [No Abstract]   [Full Text] [Related]  

  • 8. Interferons and interferon inducers: development of clinical usefulness and therapeutic promise.
    Pollard RB
    Drugs; 1982; 23(1-2):37-55. PubMed ID: 6173188
    [No Abstract]   [Full Text] [Related]  

  • 9. [Viral etiology of acute pneumonias in children and some of their epidemiological patterns in Kirghizia].
    Evdoshenko VG; Kolodin AV; Vorob'eva LM; Pokrovskaia TI; Abdykadyrova DD
    Vopr Virusol; 1973; 18(6):670-6. PubMed ID: 4364049
    [No Abstract]   [Full Text] [Related]  

  • 10. Physical and immunologic properties of rubella antigens.
    Schmidt NJ; Lennette EH; Gee PS; Dennis J
    J Immunol; 1968 Apr; 100(4):851-7. PubMed ID: 5645224
    [No Abstract]   [Full Text] [Related]  

  • 11. Respiratory virus vaccines. 3. Pentavalent respiratory syncytial-parainfluenza-mycoplasma pneumoniae vaccine.
    Sweet BH; Tytell AA; Potash L; Weibel RE; Stokes J; Drake ME; Woodhour AF; Hilleman MR
    Am Rev Respir Dis; 1966 Sep; 94(3):340-9. PubMed ID: 4288342
    [No Abstract]   [Full Text] [Related]  

  • 12. Respiratory virus vaccines. IV. Heptavalent respiratory syncytial-parainfluenza-mycoplasma-influenza vaccine in institutionalized persons.
    Woodhour AF; Sweet BH; Tytell AA; Potash L; Stokes J; Weibel RE; Metzgar DP; Hilleman MR
    Am Rev Respir Dis; 1966 Sep; 94(3):350-61. PubMed ID: 4288225
    [No Abstract]   [Full Text] [Related]  

  • 13. [Use of the IgM fraction from patients' sera in general virus serology for diagnostic purposes].
    Wolff MH; Marklein G; Schneweis KE; Stifter G
    Zentralbl Bakteriol Orig A; 1974; 227(1-4):392-400. PubMed ID: 4154618
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical evaluation of complement-fixation-reaction and hemagglutination-inhibition-test in measles of MS patients.
    Schorre E
    Int Arch Allergy Appl Immunol; 1969; 36():Suppl:121-4. PubMed ID: 4313659
    [No Abstract]   [Full Text] [Related]  

  • 15. Detection by immunofluorescence of viral, chlamydial and mycoplasma antigens in men with urethritis.
    Anghelescu S; Athanasiu P; Petrescu A; Deltin L; Dumitru N; Raica A; Serbănoiu O
    Virologie; 1985; 36(1):3-10. PubMed ID: 2988192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical application of fibroblast interferon--an overview.
    Billiau A
    Med Oncol Tumor Pharmacother; 1984; 1(2):87-96. PubMed ID: 6400034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on rubella virus. II. Hemagglutination and hemagglutination-inhibition test.
    Yamane Y; Nagashima T; Takada M; Ikumi H; Owada Y
    Kitasato Arch Exp Med; 1970 Jun; 43(1):11-21. PubMed ID: 5535193
    [No Abstract]   [Full Text] [Related]  

  • 18. [Diagnosis of para-influenza virus infection].
    Matsumoto M
    Nihon Rinsho; 1990 Feb; 48 Suppl():268-71. PubMed ID: 2162417
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of administered human interferon on experimental rabies in monkeys.
    Hilfenhaus J; Karges HE; Weinmann E; Barth R
    Infect Immun; 1975 May; 11(5):1156-8. PubMed ID: 1168171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of immunoresponses to Haemophilus gallinarum with nonviable Mycoplasma gallisepticum in chickens.
    Matsuo K; Kuniyasu C; Yamada S; Susumi S; Yamamoto S
    Avian Dis; 1978; 22(4):552-61. PubMed ID: 749885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.